North America PCR for Respiratory Infection Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase (RT-PCR), and Others), Product Type (Reagents & Kits, Instruments, and Others), Infection Type (Bacterial Infections, Viral Infections, and Fungal & Other Pathogens), and End User (Hospitals, Physician Clinics, Clinical Laboratories, Academic & Research Institutions, Biotech & Pharma Companies, and Others)

No. of Pages: 201    |    Report Code: TIPRE00024251    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America PCR for Respiratory Infection Diagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America PCR for Respiratory Infection Diagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising prevalence of respiratory infections increases the demand for rapid and accurate diagnostic solutions.
  • 5.1.3 Technological advancements in PCR methods enhance the speed and sensitivity of diagnostic tests.
  • 5.1.4 Growing awareness of the importance of early diagnosis and treatment in managing respiratory infections drives market growth.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Expansion of point-of-care testing (POCT) solutions offers new avenues for convenient and rapid diagnostics.
  • 5.2.3 Increased investment in research and development for novel PCR assays tailored to emerging respiratory pathogens.
  • 5.2.4 Rising demand for multiplex PCR tests that can simultaneously detect multiple respiratory pathogens presents significant growth potential.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Integration of artificial intelligence and machine learning in PCR diagnostics is expected to improve result accuracy and interpretation.
  • 5.3.3 Development of portable and miniaturized PCR devices will facilitate on-site testing in remote areas.
  • 5.3.4 Emphasis on personalized medicine will lead to the advancement of targeted therapies based on PCR diagnostic results.
5.4 Impact of Drivers and Restraints

6. North America PCR for Respiratory Infection Diagnostics Market Regional Analysis

6.1 North America PCR for Respiratory Infection Diagnostics Market Overview
6.2 North America PCR for Respiratory Infection Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America PCR for Respiratory Infection Diagnostics Market Forecast Analysis

7. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Type

7.1 Real-Time PCR
  • 7.1.1 Overview
  • 7.1.2 Real-Time PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Multiplex PCR
  • 7.2.1 Overview
  • 7.2.2 Multiplex PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Traditional PCR
  • 7.3.1 Overview
  • 7.3.2 Traditional PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Digital PCR
  • 7.4.1 Overview
  • 7.4.2 Digital PCR: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Reverse-Transcriptase
  • 7.5.1 Overview
  • 7.5.2 Reverse-Transcriptase: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Product Type

8.1 Reagents & Kits
  • 8.1.1 Overview
  • 8.1.2 Reagents & Kits: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Instruments
  • 8.2.1 Overview
  • 8.2.2 Instruments: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. North America PCR for Respiratory Infection Diagnostics Market Analysis – by Infection Type

9.1 Bacterial Infections
  • 9.1.1 Overview
  • 9.1.2 Instruments: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Viral Infections
  • 9.2.1 Overview
  • 9.2.2 Instruments: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Fungal & Other Pathogens
  • 9.3.1 Overview
  • 9.3.2 Instruments: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. North America PCR for Respiratory Infection Diagnostics Market – North America Analysis

10.1 North America
  • 10.1.1 North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 10.1.1.1.2 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 10.1.1.1.3 US: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
  • 10.1.1.2 Canada: North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 10.1.1.2.3 Canada: North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
  • 10.1.1.3 Mexico : North America PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
    • 10.1.1.3.3 Mexico : North America PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America PCR for Respiratory Infection Diagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Hologic, Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 BIO-RAD LABORATORIES INC.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 bioMerieux SA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 QIAGEN
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Thermo Fisher Scientific Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Seegene Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America PCR for Respiratory Infection Diagnostics Market

  1. Abbott
  2. F. HOFFMANN-LA ROCHE LTD
  3. Hologic, Inc.
  4. BD
  5. BIO-RAD LABORATORIES INC.
  6. bioMerieux SA
  7. QIAGEN
  8. Thermo Fisher Scientific Inc.
  9. Seegene Inc
north-america-pcr-for-respiratory-infection-diagnostics-market